BME:ALMPharmaceuticals
Almirall (BME:ALM) Valuation In Focus As Choppy Trading Follows Strong One Year Shareholder Return
With no single headline event driving attention today, Almirall (BME:ALM) is drawing interest for its recent share performance and current valuation metrics as investors reassess the dermatology focused biopharma group.
See our latest analysis for Almirall.
Recent trading has been choppy, with a 1 day share price return of a 6.11% decline and a 7 day share price return of a 6.8% decline. However, the 1 year total shareholder return of 35.35% suggests momentum has been positive over a longer...